Go back

Genzyme quits Cambridge

The biotechnology firm Genzyme has announced plans to close its R&D site in Cambridge by the end of the year, putting 60 jobs at risk.

The company told the online Pharmafocus news service that the site would close by the end of the year as part of global restructuring of R&D by its parent company, Sanofi.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.